Galectin Therapeutics Inc. (GALT) P/E Ratio, ROE & Key Statistics
$2.91NASDAQ: GALTMarket Cap $191.64M
Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Galectin Therapeutics Inc. (GALT), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-8.96
P/B ratioShare price divided by book value per share.
-7.70
P/S ratioMarket value divided by annual revenue.
0.00
PEG ratioP/E divided by the earnings growth rate.
-0.18
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-29.84
EV / RevenueEnterprise value against annual revenue.
0.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-11.16%
Free cash flow yieldFree cash flow as a percentage of market value.
-7.35%
Price / free cash flowMarket value divided by free cash flow.
-13.61
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
0.00%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Return on equityProfit as a percentage of shareholders’ equity.
21.65%
Return on assetsProfit as a percentage of total assets.
-178.26%
Return on capital employedOperating profit against the capital the business uses.
34.21%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.28
Quick ratioThe same, excluding inventory.
0.28
Cash ratioCash alone against current liabilities.
2.25
Debt to equityTotal borrowings against shareholders’ equity.
-0.95
Debt to assetsTotal borrowings against total assets.
6.70
Interest coverageHow many times operating profit covers the interest bill.
-2.22
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$0.48
Book value per shareShareholders’ equity divided by shares outstanding.
−$0.37
Market capitalisationShare price times shares outstanding.
$191.64M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$219.89M
EmployeesReported headcount.
15
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Galectin Therapeutics Inc. (GALT) statistics — frequently asked questions
What is Galectin Therapeutics Inc.'s P/E ratio?
Galectin Therapeutics Inc. (GALT) trades on a price-to-earnings ratio of -8.96. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Galectin Therapeutics Inc.'s return on equity?
Galectin Therapeutics Inc. (GALT) reports a return on equity of 21.65%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Galectin Therapeutics Inc. carry?
Galectin Therapeutics Inc. (GALT) has a debt-to-equity ratio of -0.95, which compares total borrowings with shareholders' equity.